Development of a measurement tool to assess public awareness of cancer

por Stubbings, S, Robb, K, Waller, J, Ramirez, A, Austoker, J, Macleod, U, Hiom, S, Wardle, J
Publicado 2009

Improving the early presentation of cancer symptoms in disadvantaged communities: putting local people in control

por Lyon, D, Knowles, J, Slater, B, Kennedy, R
Publicado 2009

Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England

por von Wagner, C, Good, A, Wright, D, Rachet, B, Obichere, A, Bloom, S, Wardle, J
Publicado 2009

A visual summary of the EUROCARE-4 results: a UK perspective

por Møller, H, Linklater, K M, Robinson, D
Publicado 2009

Public awareness of cancer in Britain: a population-based survey of adults

por Robb, K, Stubbings, S, Ramirez, A, Macleod, U, Austoker, J, Waller, J, Hiom, S, Wardle, J
Publicado 2009

Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?

por Thomson, C S, Forman, D
Publicado 2009

Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells

por Yokota, N, Koizume, S, Miyagi, E, Hirahara, F, Nakamura, Y, Kikuchi, K, Ruf, W, Sakuma, Y, Tsuchiya, E, Miyagi, Y
Publicado 2009

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

por Reardon, D A, Dresemann, G, Taillibert, S, Campone, M, van den Bent, M, Clement, P, Blomquist, E, Gordower, L, Schultz, H, Raizer, J, Hau, P, Easaw, J, Gil, M, Tonn, J, Gijtenbeek, A, Schlegel, U, Bergstrom, P, Green, S, Weir, A, Nikolova, Z
Publicado 2009

Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer

por Yoshioka, T, Kato, S, Gamoh, M, Chiba, N, Suzuki, T, Sakayori, N, Kato, S, Shibata, H, Shimodaira, H, Otsuka, K, Kakudo, Y, Takahashi, S, Ishioka, C
Publicado 2009

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families

por Ray, A M, Zuhlke, K A, Johnson, G R, Levin, A M, Douglas, J A, Lange, E M, Cooney, K A
Publicado 2009

Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells

por Murohashi, M, Hinohara, K, Kuroda, M, Isagawa, T, Tsuji, S, Kobayashi, S, Umezawa, K, Tojo, A, Aburatani, H, Gotoh, N
Publicado 2010

Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib

por Mickisch, G, Gore, M, Escudier, B, Procopio, G, Walzer, S, Nuijten, M
Publicado 2010

A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC

por Dean, E J, Ward, T, Pinilla, C, Houghten, R, Welsh, K, Makin, G, Ranson, M, Dive, C
Publicado 2010

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

por Overman, M J, Pozadzides, J, Kopetz, S, Wen, S, Abbruzzese, J L, Wolff, R A, Wang, H
Publicado 2010

Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression

por Srivastava, S, Ramdass, B, Nagarajan, S, Rehman, M, Mukherjee, G, Krishna, S
Publicado 2010

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody

por Osada, T, Hsu, D, Hammond, S, Hobeika, A, Devi, G, Clay, T M, Lyerly, H K, Morse, M A
Publicado 2010

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

por Tomlinson, I P M, Dunlop, M, Campbell, H, Zanke, B, Gallinger, S, Hudson, T, Koessler, T, Pharoah, P D, Niittymäkix, I, Tuupanenx, S, Aaltonen, L A, Hemminki, K, Lindblom, A, Försti, A, Sieber, O, Lipton, L, van Wezel, T, Morreau, H, Wijnen, J T, Devilee, P, Matsuda, K, Nakamura, Y, Castellví-Bel, S, Ruiz-Ponte, C, Castells, A, Carracedo, A, Ho, J W C, Sham, P, Hofstra, R M W, Vodicka, P, Brenner, H, Hampe, J, Schafmayer, C, Tepel, J, Schreiber, S, Völzke, H, Lerch, M M, Schmidt, C A, Buch, S, Moreno, V, Villanueva, C M, Peterlongo, P, Radice, P, Echeverry, M M, Velez, A, Carvajal-Carmona, L, Scott, R, Penegar, S, Broderick, P, Tenesa, A, Houlston, R S
Publicado 2010

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene

por Buffa, F M, Harris, A L, West, C M, Miller, C J
Publicado 2010

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy

por Henry, N L, Nguyen, A, Azzouz, F, Li, L, Robarge, J, Philips, S, Cao, D, Skaar, T C, Rae, J M, Storniolo, A M, Flockhart, D A, Hayes, D F, Stearns, V
Publicado 2010

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer

por Munkácsy, G, Abdul-Ghani, R, Mihály, Z, Tegze, B, Tchernitsa, O, Surowiak, P, Schäfer, R, Györffy, B
Publicado 2010